ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
SS Royal Kit Emirates Investment and Global Biopolymers Industries have formed Emirates Biotech, which plans to build a polylactic acid (PLA) plant in the United Arab Emirates by 2026. The company will be headed by Marc Verbruggen, who formerly led the major PLA producer NatureWorks. Emirates Biotech plans to build capacity in Africa and India as well. The sponsoring firms say the investments align with the UAE’s Green Agenda 2030 for diversifying the country’s economy with sustainable investment.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter